BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38682850)

  • 21. Multiplex fluorescence in situ hybridisation to detect anaplastic lymphoma kinase and ROS proto-oncogene 1 receptor tyrosine kinase rearrangements in lung cancer cytological samples.
    Zito Marino F; Rossi G; Cozzolino I; Montella M; Micheli M; Bogina G; Munari E; Brunelli M; Franco R
    J Clin Pathol; 2020 Feb; 73(2):96-101. PubMed ID: 31562206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory myofibroblastic tumour of the urinary bladder: the role of immunoglobulin G4 and the comparison of two immunohistochemical antibodies and fluorescence in-situ hybridization for the detection of anaplastic lymphoma kinase alterations.
    Choi E; Williamson SR; Montironi R; Zhang S; Wang M; Eble JN; Grignon DJ; Lopez-Beltran A; Idrees MT; Baldridge LA; Scarpelli M; Jones CL; Wang L; MacLennan GT; Osunkoya AO; Cheng L
    Histopathology; 2015 Jul; 67(1):20-38. PubMed ID: 25406945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spitz nevus with a novel TFG-NTRK2 fusion: The first case report of NTRK2-rearranged Spitz/Reed nevus.
    Goto K; Pissaloux D; Tirode F; de la Fouchardière A
    J Cutan Pathol; 2021 Sep; 48(9):1193-1196. PubMed ID: 33979462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent (recurrent) Spitz nevi: a histopathologic, immunohistochemical, and molecular pathologic study of 22 cases.
    Harvell JD; Bastian BC; LeBoit PE
    Am J Surg Pathol; 2002 May; 26(5):654-61. PubMed ID: 11979096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spitz melanocytic neoplasms with MLPH::ALK fusions: Report of two cases with previously unreported features and literature review.
    Salah HT; Yang RK; Roy-Chowdhuri S; Ross MI; Aung PP; Rothrock AT; Torres-Cabala CA; Curry JL; Prieto VG; Nagarajan P; Cho WC
    J Cutan Pathol; 2024 Jun; 51(6):407-414. PubMed ID: 38444194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GOPC-ROS1 mosaicism in agminated Spitz naevi: report of two cases.
    Goto K; Pissaloux D; Kauer F; Huriet V; Tirode F; de la Fouchardière A
    Virchows Arch; 2021 Sep; 479(3):559-564. PubMed ID: 33733342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ALK rearrangement in TFE3-positive renal cell carcinoma: Alternative diagnostic option to exclude Xp11.2 translocation carcinoma.
    Zhu Y; Liu N; Guo W; Pu X; Guo H; Gan W; Li D
    Pathol Res Pract; 2020 Dec; 216(12):153286. PubMed ID: 33197836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ALK rearrangement and overexpression in epithelioid fibrous histiocytoma.
    Doyle LA; Mariño-Enriquez A; Fletcher CD; Hornick JL
    Mod Pathol; 2015 Jul; 28(7):904-12. PubMed ID: 25857825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spitz Tumors With ROS1 Fusions: A Clinicopathological Study of 6 Cases, Including FISH for Chromosomal Copy Number Alterations and Mutation Analysis Using Next-Generation Sequencing.
    Donati M; Kastnerova L; Martinek P; Grossmann P; Sticová E; Hadravský L; Torday T; Kyclova J; Michal M; Kazakov DV
    Am J Dermatopathol; 2020 Feb; 42(2):92-102. PubMed ID: 31361613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spindle cell variant of epithelioid cell histiocytoma (spindle cell histiocytoma) with ALK gene fusions: Cases series and review of the literature.
    Kazlouskaya V; Ho J; Jedrych J; Karunamurthy A
    J Cutan Pathol; 2021 Jul; 48(7):837-841. PubMed ID: 33217002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas.
    Nozaki Y; Yamamoto H; Iwasaki T; Sato M; Jiromaru R; Hongo T; Yasumatsu R; Oda Y
    Hum Pathol; 2020 Dec; 106():82-92. PubMed ID: 32980422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical Spitz tumor with SQSTM1::NTRK2 fusion: Report of a case with unique spindled cell features.
    Phillips GS; Mengden-Koon S; Dhossche J; LeBoit PE; Goldstein AM; Lee I; Raffeld M; Papanicolau-Sengos A; Sargen MR; Chung J
    J Cutan Pathol; 2024 Mar; 51(3):198-204. PubMed ID: 38031352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
    Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
    Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity of anaplastic lymphoma kinase gene rearrangement in non-small-cell lung carcinomas: a comparative study between small biopsy and excision samples.
    Abe H; Kawahara A; Azuma K; Taira T; Takase Y; Fukumitsu C; Murata K; Yamaguchi T; Akiba J; Ishii H; Okamoto I; Hoshino T; Takamori S; Kage M
    J Thorac Oncol; 2015 May; 10(5):800-805. PubMed ID: 25898958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anaplastic lymphoma kinase status in rhabdomyosarcomas.
    Yoshida A; Shibata T; Wakai S; Ushiku T; Tsuta K; Fukayama M; Makimoto A; Furuta K; Tsuda H
    Mod Pathol; 2013 Jun; 26(6):772-81. PubMed ID: 23307059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Common ALK gene rearrangement in Asian CD30+ anaplastic large cell lymphoma: an immunohistochemical and fluorescence in situ hybridisation (FISH) study on paraffin-embedded tissue.
    Tai YC; Kim LH; Peh SC
    Pathology; 2003 Oct; 35(5):436-43. PubMed ID: 14555389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient.
    Pulitzer M; Ogunrinade O; Lin O; Steinherz P
    J Cutan Pathol; 2015 Mar; 42(3):182-187. PubMed ID: 25404214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217.
    Kuroda N; Trpkov K; Gao Y; Tretiakova M; Liu YJ; Ulamec M; Takeuchi K; Agaimy A; Przybycin C; Magi-Galluzzi C; Fushimi S; Kojima F; Sibony M; Hang JF; Pan CC; Yilmaz A; Siadat F; Sugawara E; Just PA; Ptakova N; Hes O
    Mod Pathol; 2020 Dec; 33(12):2564-2579. PubMed ID: 32467651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary central nervous system ALK-positive anaplastic large cell lymphoma with CD56 abnormally expression in a Chinese child: Challenge in diagnostic practice.
    Liu Q; Chen X; Li G; Ye Y; Liu W; Zhao S; Zhang W
    Int J Immunopathol Pharmacol; 2020; 34():2058738420941756. PubMed ID: 32664812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined use of ALK immunohistochemistry and FISH for optimal detection of ALK-rearranged lung adenocarcinomas.
    Sholl LM; Weremowicz S; Gray SW; Wong KK; Chirieac LR; Lindeman NI; Hornick JL
    J Thorac Oncol; 2013 Mar; 8(3):322-8. PubMed ID: 23407557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.